\Acvr1tm1Mak/\Acvr1+ \Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/\Gt(ROSA)26Sor+ \Olig2tm1.1(cre)Wdr/\Olig2+
involves: 129 * C57BL/6
|
increased oligodendrocyte number |
J:285841
|
\Acvr1tm1Mak/\Acvr1+ \Olig2tm1.1(cre)Wdr/\Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal brain development |
J:285841
|
abnormal brainstem morphology |
J:285841
|
abnormal glial cell physiology |
J:285841
|
ataxia |
J:285841
|
muscle spasm |
J:285841
|
normal
neoplasm |
J:285841
|
preweaning lethality, incomplete penetrance |
J:285841
|
\Acvr1tm1Mak/\Acvr1+ \Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/\Gt(ROSA)26Sor+ \Olig2tm1.1(cre)Wdr/\Olig2+
involves: 129 * C57BL/6 * FVB/N
|
increased brain tumor incidence |
J:285841
|
increased glioma incidence |
J:285841
|
\Acvr1tm1Mak/\Acvr1+ \Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/\Gt(ROSA)26Sor+ \H3c2tm1Mak/\H3c2+ \Olig2tm1.1(cre)Wdr/\Olig2+
involves: 129 * C57BL/6 * FVB/N
|
increased brain tumor incidence |
J:285841
|
increased glioma incidence |
J:285841
|
\Acvr1tm1Mak/\Acvr1+ \H3c2tm1Mak/\H3c2+ \Olig2tm1.1(cre)Wdr/\Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
|
normal
neoplasm |
J:285841
|
postnatal lethality, incomplete penetrance |
J:285841
|
\Cdh2tm1Glr/\Cdh2tm1Glr \Olig2tm1(cre)Tmj/\Olig2+
involves: 129S6/SvEvTac
|
abnormal neuronal migration |
J:178688
|
abnormal spinal cord morphology |
J:178688
|
abnormal spinal cord motor column morphology |
J:178688
|
lethality throughout fetal growth and development, incomplete penetrance |
J:178688
|
neonatal lethality, complete penetrance |
J:178688
|
\Cspg4tm1Ychan/\Cspg4tm1Ychan \Olig2tm2(TVA,cre)Rth/\Olig2+
involves: 129 * C57BL/6N
|
decreased body weight |
J:184220
|
decreased epididymal fat pad weight |
J:184220
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Juptm1Ruiz/\Juptm1.1Tmj \Olig2tm1(cre)Tmj/\Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
abnormal dendrite morphology |
J:178688
|
lethality throughout fetal growth and development, complete penetrance |
J:178688
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Juptm1Ruiz/\Juptm1Ruiz \Olig2tm1(cre)Tmj/\Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
abnormal neuronal migration |
J:178688
|
abnormal spinal cord lateral motor column morphology |
J:178688
|
abnormal spinal cord medial motor column morphology |
J:178688
|
abnormal spinal cord motor column morphology |
J:178688
|
abnormal ventral interneuron 1 morphology |
J:178688
|
abnormal ventral interneuron 2 morphology |
J:178688
|
decreased motor neuron number |
J:178688
|
embryonic lethality during organogenesis, complete penetrance |
J:178688
|
normal
nervous system phenotype |
J:178688
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Olig2tm1(cre)Tmj/\Olig2+
involves: 129S1/Sv * 129X1/SvJ
|
abnormal spinal cord medial motor column morphology |
J:178688
|
decreased motor neuron number |
J:178688
|
neonatal lethality, complete penetrance |
J:178688
|
\Gt(ROSA)26Sorem2(Mios)Bcgen/\Gt(ROSA)26Sor+ \Miostm1Pfw/\Miostm1Pfw \Olig2tm2(TVA,cre)Rth/\Olig2+
involves: 129 * C57BL/6
|
normal
nervous system phenotype |
J:320720
|
\Gt(ROSA)26Sortm1(Hoxa2)Fmr/\Gt(ROSA)26Sor+ \Olig2tm2(TVA,cre)Rth/\Olig2+
involves: 129P2/OlaHsd
|
abnormal brain development |
J:193058
|
decreased oligodendrocyte progenitor number |
J:193058
|
\Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/\Gt(ROSA)26Sor+ \Olig2tm1.1(cre)Wdr/\Olig2+
involves: 129 * C57BL/6 * FVB/N
|
normal
neoplasm |
J:285841
|
\Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/\Gt(ROSA)26Sor+ \H3c2tm1Mak/\H3c2+ \Olig2tm1.1(cre)Wdr/\Olig2+
involves: 129 * C57BL/6 * FVB/N
|
normal
neoplasm |
J:285841
|
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/\Gt(ROSA)26Sortm1(Smo/EYFP)Amc \Olig2tm2(TVA,cre)Rth/\Olig2+
involves: 129 * 129X1/SvJ
|
increased medulloblastoma incidence |
J:139574
|
premature death |
J:139574
|
\Mapttm1(Sema3e)Yuyo/\Mapt+ \Olig2tm1(cre)Tmj/\Olig2+
Not Specified
|
abnormal excitatory postsynaptic potential |
J:205528
|
abnormal sensory neuron innervation pattern |
J:205528
|
abnormal synaptic bouton morphology |
J:205528
|
normal
nervous system phenotype |
J:205528
|
\Miostm1Pfw/\Miostm1Pfw \Olig2tm2(TVA,cre)Rth/\Olig2+
involves: 129 * C57BL/6
|
abnormal oligodendrocyte physiology |
J:320720
|
normal
behavior/neurological phenotype |
J:320720
|
decreased oligodendrocyte number |
J:320720
|
dysmyelination |
J:320720
|
\Myrftm1Barr/\Myrftm1Barr \Olig2tm2(TVA,cre)Rth/\Olig2+
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6
|
abnormal myelination |
J:150563
|
abnormal optic nerve morphology |
J:150563
|
abnormal spinal cord morphology |
J:150563
|
ataxia |
J:150563
|
normal
nervous system phenotype |
J:150563
|
postnatal lethality, complete penetrance |
J:150563
|
seizures |
J:150563
|
tremors |
J:150563
|
\Ntf3tm2.1Jae/\Ntf3tm2Jae \Olig2tm2(cre)Htak/\Olig2+
involves: ICR
|
abnormal dorsal root ganglion morphology |
J:182750
|
abnormal proprioceptive neuron morphology |
J:182750
|
abnormal sensory neuron innervation pattern |
J:182750
|
\Olig1tm1And/\Olig1tm1And \Olig2tm1And/\Olig2tm1And
involves: 129 * C57BL/6J
|
abnormal nervous system development |
J:76446
|
abnormal ventral interneuron 2 morphology |
J:76446
|
absent oligodendrocytes |
J:76446
|
decreased fetal size |
J:76446
|
decreased motor neuron number |
J:76446
|
decreased oligodendrocyte progenitor number |
J:76446
|
perinatal lethality, complete penetrance |
J:76446
|
\Olig1tm1And/\Olig1tm1And \Olig2tm1And/\Olig2tm1And \Tg(Olig2)#Wdr/?
Not Specified
|
abnormal oligodendrocyte morphology |
J:210099
|
\Olig2tm1(cre)Tmj/\Olig2+ \Shhtm2Amc/\Shhtm2Amc
involves: 129S1/Sv * 129X1/SvJ
|
abnormal spinal cord lateral motor column morphology |
J:277700
|
decreased motor neuron number |
J:277700
|
normal
nervous system phenotype |
J:277700
|
\Olig2tm1(cre)Tmj/\Olig2+ \Smn1tm1Jme/\Smn1tm1Msd \Grm7Tg(SMN2)89Ahmb/\Grm7+
involves: 129 * 129P2/OlaHsd * FVB/N
|
postnatal lethality, complete penetrance |
J:164292
|
\Olig2tm1(cre)Tmj/\Olig2+ \Smn1tm1Jme/\Smn1tm1Msd \Grm7Tg(SMN2)89Ahmb/\Grm7Tg(SMN2)89Ahmb
involves: 129 * 129P2/OlaHsd * FVB/N
|
abnormal CNS synaptic transmission |
J:164292
|
abnormal miniature endplate potential |
J:164292
|
abnormal muscle morphology |
J:164292
|
abnormal neuromuscular synapse morphology |
J:164292
|
abnormal PNS synaptic transmission |
J:164292
|
abnormal sensory neuron innervation pattern |
J:164292
|
abnormal synaptic bouton morphology |
J:164292
|
abnormal synaptic transmission |
J:164292
|
decreased body weight |
J:164292
|
decreased grip strength |
J:164292
|
decreased skeletal muscle fiber number |
J:164292
|
decreased survivor rate |
J:164292
|
increased skeletal muscle fiber size |
J:164292
|
kyphosis |
J:164292
|
motor neuron degeneration |
J:164292
|
muscle weakness |
J:164292
|
muscular atrophy |
J:164292
|
premature death |
J:164292
|
skeletal muscle fiber degeneration |
J:164292
|
\Polr3atm1Iwil/\Polr3atm1Iwil \Olig2tm1.1(cre)Wdr/\Olig2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
abnormal brain white matter morphology |
J:311745
|
abnormal object recognition memory |
J:311745
|
abnormal oligodendrocyte physiology |
J:311745
|
abnormal spatial reference memory |
J:311745
|
decreased body size |
J:311745
|
decreased body weight |
J:311745
|
decreased myelin sheath thickness |
J:311745
|
decreased oligodendrocyte number |
J:311745
|
decreased startle reflex |
J:311745
|
dysmyelination |
J:311745
|
increased thermal nociceptive threshold |
J:311745
|
motor developmental delay |
J:311745
|
slow postnatal weight gain |
J:311745
|
\Prrc2atm1Fcw/\Prrc2atm1Fcw \Olig2tm2(TVA,cre)Rth/\Olig2+
involves: 129 * C57BL/6
|
abnormal brain morphology |
J:301796
|
abnormal corpus callosum morphology |
J:301796
|
decreased body weight |
J:301796
|
decreased grip strength |
J:301796
|
decreased oligodendrocyte number |
J:301796
|
decreased oligodendrocyte progenitor number |
J:301796
|
dysmyelination |
J:301796
|
enlarged lateral ventricles |
J:301796
|
impaired coordination |
J:301796
|
impaired spatial learning |
J:301796
|
increased brain weight |
J:301796
|
normal
nervous system phenotype |
J:301796
|
premature death |
J:301796
|